Comparing Dabigatran vs Rivaroxaban
| Dabigatran | Rivaroxaban |
|
|---|
| Dabigatran | Rivaroxaban |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Prevention of Thromboembolism in Atrial Fibrillation, Deep Vein Thrombosis - Prophylaxis, Pulmonary Embolism, Deep Vein Thrombosis, Deep Vein Thrombosis/Pulmonary Embolism Prophylaxis... View more |
Prescription only
Prescribed for Atrial Fibrillation, Cardiovascular Risk Reduction, Coronary Artery Disease, Congenital Heart Disease, Deep Vein Thrombosis, Deep Vein Thrombosis Prophylaxis after Hip Replacement... View more |
Related suggestions Prevention of Thromboembolism in Atrial Fibrillation
|
|||||||||||||||
| More about Dabigatran | More about Rivaroxaban | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Dabigatran has an average rating of 6.9 out of 10 from a total of 102 ratings on Drugs.com. 51% of reviewers reported a positive effect, while 13% reported a negative effect. |
Rivaroxaban has an average rating of 5.3 out of 10 from a total of 251 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 43% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Dabigatran side effects |
View all Rivaroxaban side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Dabigatran prices |
View all Rivaroxaban prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Pradaxa | Xarelto | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
17 hours |
13 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 306 drugs are known to interact with Dabigatran:
|
A total of 389 drugs are known to interact with Rivaroxaban:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
October 19, 2010 |
July 01, 2011 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
|
|||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.